A Rift Over Carl Linnaeus Shows We Shouldn’t Idolize Scientists
By Brian Lovett,
Undark
| 08. 06. 2020
The traditions we carry into the future, including who we choose to honor, should be able to withstand modern scrutiny.
WE ARE LIVING through a period of cultural upheaval. Around the world, statues of iconic men who held racist beliefs and committed racial injustices are being ripped from their pedestals. The dull thud of metal bodies hitting concrete rings fresh in our ears, and many of us are still grappling with what these reverberations mean.
Statues of racists are monuments to the dregs of our society. Yet over time, their pedestals have crept so high that, for some people, it has become unthinkable that any scandal could justify their removal. Today, these memorialized men look down on us from high places that they do not deserve; the scandal is that society has for so long respected the inertia of their corrupting influence.
One such figure is the 18th century Swedish botanist Carl Linnaeus. He devised binomial nomenclature, the ubiquitous system now used to scientifically classify organisms by genus and species. He then used his nomenclature to classify humans by “variety,” ascribing inherently positive traits to lighter-skinned Europeans and negative traits to darker-skinned Africans and Asians, thereby laying a pseudoscientific foundation for...
Related Articles
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Rob Stein, NPR | 07.16.2025
Scientists can protect children from being born with certain devastating genetic disorders by creating "three-parent" babies, according to the results of a landmark study released Wednesday.
British researchers used the experimental technique to help families have eight children who appear...